Killer cell immunoglobulin‐like receptor gene's repertoire in rheumatoid arthritis

References

• Yen J. H., Chen J. R., Tsai W. J., Tsai J. J., Liu H. W. HLA‐DRB1 genotyping in patients with rheumatoid arthritis in Taiwan. J Rheumatol 1995; 22: 1450–4
   PubMedGoogle Scholar
• Moretta A., Sivori S., Vitale M., Pende D., Morelli L., Augugliaro R., et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA‐C molecules in human natural killer cells. J Exp Med 1995; 182: 875–84
   PubMed Web of Science ®Google Scholar
• Biassoni R., Cantoni C., Falco M., Verdiani S., Bottino C., Vitale M., et al. The human leukocyte antigen (HLA)‐C‐specific ‘activatory’ or ‘inhibitory’ natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996; 183: 645–50
   PubMed Web of Science ®Google Scholar
• Lanier L. L. NK cell receptors. Annu Rev Immunol 1998; 16: 359–93
   PubMed Web of Science ®Google Scholar
• Ryan J. C., Naper C., Hayashi S., Daws M. R. Physiologic functions of activating natural killer (NK) complex‐encoded receptors on NK cells. Immunol Rev 2001; 181: 126–37
   PubMed Web of Science ®Google Scholar
• Middleton D., Curran M., Maxwell L. Natural killer cells and their receptors. Transpl Immunol 2002; 10: 147–64
   PubMed Web of Science ®Google Scholar
• Katz G., Markel G., Mizrahi S., Arnon T. I., Mandelboim O. Recognition of HLA‐Cw4 but not HLA‐Cw6 by the NK cell receptor killer cell Ig‐like receptor two‐domain short tail number 4. J Immunol 2001; 166: 7260–7
   PubMed Web of Science ®Google Scholar
• Namekawa T., Snyder M. R., Yen J. H., Goehring B. E., Leibson P. J., Weyand C. M., et al. Killer cell activating receptors function as costimulatory molecules on CD4+ CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 2000; 165: 1138–45
   PubMed Web of Science ®Google Scholar
• Weyand C. M., Goronzy J. J., Liuzzo G., Kopecky S. L., Holmes DR J. r., Frye R. L. T‐cell immunity in acute coronary syndromes. Mayo Clin Proc 2001; 76: 1011–20
   PubMed Web of Science ®Google Scholar
• Yen J. H., Moore B. E., Nakajima T., Scholl D., Schaid D. J., Weyand C. M., et al. Major histocompatibility complex class I‐recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001; 193: 1159–67
   PubMed Web of Science ®Google Scholar
• Uhrberg M., Valiante N. M., Shum B. P., Shilling H. G., Lienert‐Weidenbach K., Corliss B., et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753–63
   PubMed Web of Science ®Google Scholar
• Borrego F., Kabat J., Kim D. K., Lieto L., Maasho K., Pena J., et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2002; 38: 637–60
   PubMed Web of Science ®Google Scholar
• Trowsdale J., Barten R., Haude A., Stewart C. A., Beck S., Wilson M. J. The genomic context of natural killer receptor extended gene families. Immunol Rev 2001; 181: 20–38
   PubMed Web of Science ®Google Scholar
• Biassoni R., Cantoni C., Pende D., Sivori S., Parolini S., Vitale M., et al. Human natural killer cell receptors and co‐receptors. Immunol Rev 2001; 181: 203–14
   PubMed Web of Science ®Google Scholar
• Chouaib S., Thiery J., Gati A., Guerra N., El Behi M., Dorothee G., et al. Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell death. Tissue Antigens 2002; 60: 273–81
   PubMedGoogle Scholar
• Lopez‐Botet M., Angulo A., Guma M. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 2004; 63: 195–203
   PubMedGoogle Scholar
• Vampa M. L., Norman P. J., Burnapp L., Vaughan R. W., Sacks S. H., Wong W. Natural killer‐cell activity after human renal transplantation in relation to killer immunoglobulin‐like receptors and human leukocyte antigen mismatch. Transplantation 2003; 76: 1220–8
   PubMedGoogle Scholar
• Varla‐Leftherioti M., Spyropoulou‐Vlachou M., Niokou D., Keramitsoglou T., Darlamitsou A., Tsekoura C., et al. Natural killer (NK) cell receptors' repertoire in couples with recurrent spontaneous abortions. Am J Reprod Immunol 2003; 49: 183–91
   PubMed Web of Science ®Google Scholar
• Vilches C., Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217–51
   PubMed Web of Science ®Google Scholar
• Maxwell L. D., Wallace A., Middleton D., Curran M. D. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002; 60: 254–8
   PubMedGoogle Scholar
• Momot T., Koch S., Hunzelmann N., Krieg T., Ulbricht K., Schmidt R. E., et al. Association of killer cell immunoglobulin‐like receptors with scleroderma. Arthritis Rheum 2004; 50: 1561–5
   PubMed Web of Science ®Google Scholar
• Martin M. P., Nelson G., Lee J. H., Pellett F., Gao X., Wade J., et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig‐like receptor genes in the absence of specific HLA‐C alleles. J Immunol 2002; 169: 2818–22
   PubMed Web of Science ®Google Scholar